Phase I Study of Proton Therapy in Adjuvant Pancreatic Cancer (Proton-PANC)
The purpose of this phase I trial is to determine a safe schedule of short-course proton beam radiation therapy with adjuvant mFOLFIRINOX for patients with resected pancreatic adenocarcinoma.
Study ID: 2018-1021
Trial Phase: Phase I
Trial Sponsor: Georgetown University
Therapies Used in This Trial: Fluorouracil, Oxaliplatin, Proton Radiation, Irinotecan, Leucovorin, FOLFIRINOX